KLS Keeping Law Simple Legislation in plain English

Straight-ahead summaries built from the official bill text. We keep the source links front and center and leave the decision up to you.

Back to Massachusetts

SD3797 • 2025

Special Commission on the Public Health Effects of Xylazine Final Report

Special Commission on the Public Health Effects of Xylazine Final Report

Active

The official status still shows this bill as active or still awaiting another formal step.

Sponsor
Special Commission on Public Health Effects of Xylazine
Last action
2026-03-30
Official status
Placed on file
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

Special Commission on the Public Health Effects of Xylazine Final Report

Special Commission on the Public Health Effects of Xylazine Final Report Report of the Special Commission on Public Health Effects of Xylazine (pursuant to Section 36 of Chapter 285 of the Acts of 2024) submitting its recommendations and final report on ways to address the public health and safety concerns posed by the proliferation of xylazine as an additive to illicit drugs including, but not limited to, fentanyl

What This Bill Does

  • Special Commission on the Public Health Effects of Xylazine Final Report Report of the Special Commission on Public Health Effects of Xylazine (pursuant to Section 36 of Chapter 285 of the Acts of 2024) submitting its recommendations and final report on ways to address the public health and safety concerns posed by the proliferation of xylazine as an additive to illicit drugs including, but not limited to, fentanyl

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

  1. 2026-03-30 Senate

    Placed on file

Official Summary Text

Special Commission on the Public Health Effects of Xylazine Final Report
Report of the Special Commission on Public Health Effects of Xylazine (pursuant to Section 36 of Chapter 285 of the Acts of 2024) submitting its recommendations and final report on ways to address the public health and safety concerns posed by the proliferation of xylazine as an additive to illicit drugs including, but not limited to, fentanyl

Current Bill Text

Read the full stored bill text 
×

Bill SD.3797

The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

Close